Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-003484
Filing Date
2025-05-27
Accepted
2025-05-27 16:31:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5531
  Complete submission text file 0001950047-25-003484.txt   6929
Mailing Address 6340 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517
Business Address
Hahn Mark W (Reporting) CIK: 0001408502 (see all company filings)

Type: 144

Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Subject) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38067 | Film No.: 25989060
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)